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Abstract
Background—Bipolar disorder is frequently misdiagnosed as major depressive disorder delaying
appropriate treatment and worsening outcome for many bipolar individuals. Emotion dysregulation
is a core feature of bipolar disorder. Measures of dysfunction in neural systems supporting emotion
regulation may therefore help discriminate bipolar from major depressive disorder.
Methods—Thirty-one depressed individuals, 15 bipolar depressed (BD) and 16 major depressed
(MDD), DSM-IV diagnostic criteria, aged 18–55 years, matched for age, age of illness onset, illness
duration, depression severity, and 16 age- and gender-matched healthy controls (HC) performed two
event-related paradigms: labeling the emotional intensity of happy and sad faces, respectively. We
employed dynamic causal modeling to examine significant among-group alterations in effective
connectivity (EC) between right-and left-sided neural regions supporting emotion regulation:
amygdala and orbitomedial prefrontal cortex (OMPFC).
Results—During classification of happy faces, we found profound and asymmetrical differences
in effective connectivity between the OMPFC and amygdala. Left-sided differences involved top-
down connections and discriminated between depressed and control subjects. Furthermore, greater
medication load was associated with an amelioration of this abnormal top-down EC. Conversely, on
the right side the abnormality was in bottom-up EC that was specific to bipolar disorder. These effects
replicated when we considered only female subjects.
Conclusions—Abnormal left-sided top-down OMPFC-amygdala and right-sided bottom-up
amygdala-OMPFC EC during happy labeling distinguish BD and MDD, suggesting different
pathophysiological mechanisms associated with the two types of depression.
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Introduction
Bipolar disorder is one of the ten most debilitating illnesses worldwide(1), with a prevalence
of at least 1%, poor clinical and functional outcome, a high suicide rate(2) and a huge societal
cost(3). Among the reasons contributing to the illness’s poor prognosis are the frequent
misdiagnosis and late diagnosis of the disorder(4), leading to delays in appropriate treatment.
Bipolar depression, the most frequent presentation, continues to be frequently misdiagnosed
and inappropriately treated as major depressive disorder in individuals without a clear previous
history of mania(3,5–7), while 35% of bipolar individuals take more than 10 years to receive
a correct diagnosis(5). Increased accuracy in diagnosing bipolar disorder during depression as
early as possible in illness course therefore remains a key goal to help improve the treatment
and functional outcome of individuals with bipolar disorder.
Emotion dysregulation is a key clinical feature of bipolar disorder(8). Examination of
functional abnormalities in key neural regions and systems supporting emotion processing and
emotion regulation is therefore a promising way forward in the search for candidate biomarkers
of bipolar disorder(9–11) that, in turn, may help improve diagnosis of bipolar disorder(12,
13). These key neural regions include the amygdala (important for emotion processing) and
orbitomedial prefrontal cortex(OMPFC, including Brodmann Areas 11, 47 and 25), involved
in different emotion regulatory subprocesses(14). An increasing number of functional
neuroimaging studies have provided evidence for abnormal OMPFC and amygdala activity in
bipolar disorder during emotion processing, especially during facial emotion processing(15).
These studies reported greater subcortical limbic activity(amygdala, ventral striatum and
hippocampus) to positive(happy) and negative (sad and fearful) emotional facial expressions
in depressed, manic(16–18) and euthymic bipolar disorder(19–21) versus healthy adults,
although some did not report increased amygdala and striatal activity to fearful faces in
euthymic or stable bipolar disorder adults.
We recently examined OMPFC-amygdala anatomical connectivity in bipolar disorder and
healthy adults using diffusion tensor imaging(DTI) and fractional anisotropy(FA)(22). Our
major finding was a right-left asymmetry in fiber alignment in the uncinate fasciculus(UF)
connecting OMPFC and amygdala. Specifically, we showed in bipolar disorder relative to
healthy adults abnormally elevated left-sided UF FA(that may reflect greater longitudinal
directional alignment of myelinated fibers in the uncinatefasciculus) and abnormally reduced
right-sided UF FA(that may reflect more obliquely-oriented fibers in the uncinate fasciculus)
(22). Our findings in this study parallel others showing an increased number of reconstructed
longitudinally-aligned fibers in the left UF in bipolar disorder adults(23,24) or abnormal UF
FA(25–27), and those reporting abnormal UF FA in psychosis and schizotypic(28–30).
These findings allowed us to postulate that abnormal right-left asymmetry in OMPFC-
amygdala anatomic connectivity may relate to abnormal left versus right hemispheric
processing of emotion that has previously been demonstrated in major depressive disorder
depression(31,32), and may also represent a pathophysiologic mechanism for emotion
dysregulation in bipolar disorder.
Few studies, however, have examined the extent to which abnormal functional integration
between amygdala and OMPFC characterizes bipolar disorder. Functional connectivity(FC)
refers to a correlation over time between activities in different neural regions. In contrast,
effective connectivity(EC) refers to the impact that activity in one region exerts over that in
another, and can be used to estimate forward(bottom-up) versus backward(top-down)
connectivity between regions. EC can be examined using dynamic causal modeling(DCM), a
technique for estimating, and making inferences about, the negative or positive influence that
one region exerts over another, and how this is affected by experimental context(33). Only one
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study has examined FC in bipolar disorder. In this study reduced FC between ventrolateral
prefrontal cortex and amygdala was reported in manic bipolar disorder relative to healthy
individuals during an emotion-labeling task(34). No previous studies have yet examined
OMPFC-amygdala EC in bipolar disorder. Thus, the extent to which different patterns of
abnormal functional integration between OMPFC and amygdala may distinguish bipolar
disorder from major depressive disorder depression is also unknown.
We employed DCM and well-validated positive and negative emotion processing experiments
(labeling happy and sad facial emotion experiments) to examine the extent to which:
1. Bipolar disorder and major depressive disorder depressed adults would show
abnormal right and left top-down OMPFC-amygdala and/or bottom-up amygdala-
OMPFC EC during happy and sad emotion processing;
2. Bipolar disorder and major depressive disorder depression would be associated with
different patterns of abnormal right and left top-down and/or bottom-up EC between
these regions.
METHODS and MATERIALS
Participants
The University of Pittsburgh Institutional Review Board approved the study protocol. Sixteen
healthy control participants(HC) with no previous personal or family history of psychiatric
illness in first and second degree relatives participated in the study. Thirty-one adults: fifteen
with bipolar disorder, type I in depressed episode(BD) and sixteen with major depressive
disorder in depressed episode(MDD), diagnosed according to DSM-IV criteria and the
Structured Clinical Interview for DSM-IV, Research Version(SCID-P), participated in the
study. MDD and BD did not differ in age(U=91,p=0.3), gender(χ2(1)=1,p=0.6), Hamilton
Depression Rating Scale(HDRS-25: U=82,p=0.13), age of illness onset(U=105.5,p=0.6) and
illness duration(U=115,p=0.084). BD subjects had significantly greater medication load,
reflecting greater number and dose of different psychotropic medications(U=51,p=0.006, see
supplemental material for further information about computation of medication load and
detailed participant medication information; Table S1), because they were being treated for
BD rather than MDD depression. All had experienced at least two episodes of illness in the
last 4 years. Some BD and some MDD had lifetime history of substance abuse or dependence
disorders, and most were medicated(four were medication-free: two BD and two MDD;
Table1). HC, MDD and BD depressed groups were age- and gender-ratio-matched (χ2(2)
=1.6,p=0.4 and χ2(2)=1.9,p=0.5, respectively; Table1). All participants were right-handed and
native English speaking. All participants were aware of the purpose of the study and gave
written informed consent after explanation of the purpose of the research before participation
in the study.
Exclusion criteria included history of head injury(from medical records and participant report),
systemic medical illness, cognitive impairment(score<24 in the Mini-Mental State
Examination, premorbid IQ estimate<85 using the National Adult Reading Test), Axis-II
borderline personality disorder, and general exclusion criteria for MRI(presence/questionable
history of metallic objects in the body, positive pregnancy test/self-reporting of pregnancy, and
proneness to panicking in enclosed spaces). For HC, current alcohol and illicit substance abuse
(determined by SCID-I, saliva and urine screen) were further exclusion criteria.
Paradigm
All individuals participated in two(happy and sad) 6-minute event-related experiments. Each
experiment involved viewing 60 facial expressions from a standardized series(35). Individuals
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viewed 20 prototypically happy(or sad) expressions; 20 mild happy (or sad) expressions, and
20 neutral expressions to represent the range of intensities of happy or sad emotion in each
experiment. Each facial expression was presented for 2 seconds, with an inter-stimulus interval
(ISI) of variable duration, according to a Poisson distribution (mean ISI=4.9s). We chose happy
and sad facial expressions as examples of emotional stimuli as previous functional
neuroimaging studies demonstrated abnormally increased activity in subcortical limbic regions
(e.g. amygdala) and OMPFC to these specific emotional stimuli in BD and MDD(19,21,36–
38). Participants were asked to label the emotion of each face by moving either the index
(emotional faces) or middle finger(neutral faces) of the right hand to ensure that attention was
directed to the emotional content of the face(see supplemental material for a schematic
representation of the experiment). The labeling of emotional faces paradigm required subjects
to consciously attend to(think about) the emotional content of the face stimuli; thus, neuronal
activation in our regions of interest were very likely to encode the emotional valence and
intensity of the stimuli.
In the present study, we focus on main findings from DCM analyses. See Supplemental
Material for analysis and findings of standard functional specialization analyses regarding
amygdala and OMPFC regions using SPM5 software(http://www.fil.ion.ucl.ac.uk/spm/; and
Table S2), that shows that there were main effects of condition in OMPFC and amygdala BOLD
signal for both experiments, a main effect of group for amygdala BOLD signal in the sad
experiment, and group x interaction upon amygdala BOLD response in the happy experiment.
Functional integration: Dynamic Causal Modelling analyses
We chose bilateral amygdala and bilateral orbitomedial prefrontal cortex(OMPFC; specifically
the BA11) as regions of interest for DCM analyses based on their known importance to emotion
processing and emotion regulation, respectively, and their interconnections in both bottom-up
and top-down directions via the UF, that we previously reported as abnormal in BD(22). We
used DCM(33,39) in SPM5 software, to examine between group differences in right and left
bottom-up amygdala-OMPFC and top-down OMPFC-amygdala EC. The aim of DCM is to
estimate, and make inferences about, the influence that one neural system exerts over another
and how the experimental context affects the neural system. In DCM, a reasonably realistic
but simple neural model of interacting neural regions is constructed. DCM uses a previously-
validated biophysical model of functional MRI measurements to estimate underling neuronal
responses from observed hemodynamic responses(40); estimated underlying neuronal
responses are then used to derive connectivity parameters, as described elsewhere(33). The
neuronal(connectivity) and hemodynamic parameters are optimised using a variational
expectation maximisation scheme(33). In this study we were primarily interested in the
endogenous or baseline connectivity between the amygdala and OMPFC during emotional
processing and the group-specific or between subject-differences in this coupling. To assess
these differences we used a conventional summary statistic approach, where the within-subject
estimates of coupling were passed to a second(between-subject) level for classical inference.
Note that we did not use bilinear or modulatory terms in our DCM(to model changes in
connectivity associated with emotional intensity). However, because we optimized the
coupling parameters for DCMs in the happy and sad paradigms, we implicitly allow for the
effects of emotional valence on coupling. In the following analyses, one can regard the
estimates of top-down and bottom-up coupling as effective connectivity, subtending face
processing, in the context of either happy or sad face judgments. Moreover, in the emotion
labeling experiment the subjects had to consciously “think” about the emotion; therefore the
valence and intensity are implicitly embedded in the neural activation in the DCM model.
For each session(i.e., subject and experiment) we modelled fMRI responses with one single
DCM. This comprised bilateral amygdala and orbitofrontal cortical regions that were
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connected, reciprocally with forward(bottom-up) and backwards(top-down) ipsilateral
connections(Figure1). This provided eight effective connectivity estimates for each subject
that were estimated under happy or sad experiments, in the right or left hemisphere, and were
either forward or backwards. To account for individual differences, we extracted principal
eigenvariates to summarize regional responses in anatomical templates centered on the regions
above created with the Wake Forest University(WFU) Pick Atlas. The stimulus function, that
encoded face presentation per se, entered each dynamic causal model through the amygdala
and propagated to OMPFC via bottom-up, and back to the amygdala via top-down
interconnections between the two regions(Figure1).
In DCM, the units of connections are per unit time and therefore correspond to rates: a strong
connection means an influence that is expressed quickly or with a large rate-constant. A positive
(i.e., greater than zero) endogenous connection indicates that “high” activity in the “source”
region is associated with an increase in activity in the “target” region. Similarly for negative
connections. The underlying model links rates of change in the target to the level of activity
in the source(33).
Between-group differences in EC
Individual-specific estimates of EC were next entered into SPSS edition 15(SPSS Inc.) for
examination with Kruskal-Wallis tests of the between group differences upon right and left
bottom-up and top-down OMPFC-amygdala EC for happy and sad experiments. Each test was
thresholded at p=0.006 to correct for the eight separate Kruskal-Wallis tests: one test for each
laterality, emotion and direction. We deliberately decided to be very conservative in this
multiple test correction because of the novelty of our study. Post hoc Mann-Whitney U tests
were employed for subsequent between-group pairwise comparisons for each EC parameter
showing a significant group difference(p<0.02, to control for three pairwise between-group
tests). Non-parametric tests were employed because EC measures were not normally
distributed. Significant between-group differences in EC were then explored for possible
relationships using Spearman rank correlation tests and Man-Whitney U tests, as appropriate,
with the following variables: age, age of illness onset, illness duration, depression severity
measured using the HRSD25, medication load, individual psychotropic medication classes and
lifetime history of comorbid substance disorder, using a statistical threshold of p=0.05, as these
were exploratory analyses.
RESULTS
Behavioral Analyses
There were no differences among groups in labeling of emotional face in both experiments
(p>0.05-Table1). Moreover, no emotion labeling differences were found between the two
depressed groups(p>0.1–Table1).
Neuroimaging Data Analyses
Functional integration – Dynamic Causal Modeling: between group differences
in EC—There was a significant group difference upon left-sided top-down OMPFC-amygdala
EC during the happy experiment(χ2(2)=11.5,p=0.003; Table 2). Relative to HC, both MDD
and BD had significantly reduced EC(MDD: U=52,p=0.004, Cohen’s d effect size=0.95 and
BD: U=52,p=0.007, d=0.65; Figure 2 and Table 3), although BD and MDD did not differ
significantly on this measure. Observation of group-specific values revealed that this EC was
positive in HC, close to zero in BD and negative in MDD(Table 2).
There was a between-group difference in right-sided bottom-up amygdala-OMPFC EC in the
happy experiment(χ2(2)=9.9,p=0.007) that just failed to meet our stringent threshold for
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significance(0.006, controlling for multiple tests). This EC differed significantly between HC
and BD (U=42, p=0.002; d=1.2) but not between MDD and HC(Table 3 and Figure2). MDD
and BD differed on this measure, but at a threshold that failed to meet correction for multiple
tests (U=64,p=0.027; d=0.42). Observation of group-specific values indicated that right-sided
bottom-up amygdala-OMPFC EC was positive in HC and MDD but negative in BD(Table 2
and Table 3).
In the sad experiment, there was a trend between-group difference in left-sided top-down
OMPFC-amygdala EC(χ2(2)=8.8,p=0.01). MDD and BD both had significantly reduced left-
sided top-down OMPFC-amygdala EC relative to HC(U=61.5,p=0.012, d=0.31 and
U=55.5,p=0.011, d=0.42, respectively). BD and MDD did not differ significantly on this EC
measure(Table 3).
Relationships between abnormal EC and illness history, medication load and
demographic variables—Correlation analyses using Spearman Rank correlation tests were
performed to examine relationships between clinical variables, left-sided top-down OMPFC-
amygdala EC during the happy and sad experiments and right-sided bottom-up amygdala-
OMPFC EC during the happy experiment in BD and MDD(Table 4).
Left-sided top-down OMPFC-amygdala EC in the happy experiment was positively correlated
with medication load in MDD(rs=0.64, p=0.007), i.e., the greater the medication load, more
positive the EC. There was also a negative relationship between this EC measure and age of
illness onset in MDD(rs=−0.5, p=0.05). MDD taking, versus those not taking, benzodiazepines
had greater left-sided top-down OMPFC-amygdala EC during the happy experiment(U=6,
p=0.01). There was a trend association only between taking antipsychotics and this EC measure
in BD.
For the right-sided bottom-up amygdala-OMPFC EC during the happy experiment, there was
a negative relationship in MDD only with medication load(rs=−0.6, p=0.01): the greater the
medication load, the closer to zero the EC.
In the sad experiment, performance showed a negative trend correlation with left-sided top-
down OMPFC-amygdala EC when labeling the neutral faces in MDD.
There were no significant correlations between EC and age in both depressed groups.
In HC there were no significant relationships between EC and age at scan(happy left-side top-
down EC: rs=0.2, p=0.6; happy right-sided bottom-up EC: rs=0.4, p=0.2; and sad left-sided
top-down EC: rs=−0.3, p=0.4) and experiment accuracy(happy left-side top-down EC
emotional faces: rs=0.3, p=0.2; neutral faces: rs=0.4, p=0.1; happy right-sided bottom-up EC
emotional faces: rs=−0.1, p=0.8; neutral faces: rs=−0.1, p=0.8; and sad left-sided top-down EC
emotional faces: rs=0.2, p=0.4; neutral faces: rs=−0.003, p=0.99).
As the majority of study participants were female, and to exclude potential effects of gender
upon EC in each group, we further examined EC in females only. In this subgroup we found
exactly the same pattern of group differences: left-sided top-down OMPFC-amygdala EC
(χ2(2)=10.64, p=0.005) and right-sided bottom-up amygdala-OMPFC EC (χ2(2)=9.55,
p=0.008) in the happy experiment, and a trend difference in left top-down OMPFC-amygdala
EC in the sad experiment(χ2(2)=6.45, p=0.04). In the left-sided top-down OMPFC-amygdala
EC during the happy experiment there were differences between MDD and HC(U=25, p=0.004;
d=0.97), BD and HC(U=46,p=0.05; d=0.36), and between depressed groups(U=49.5,p=0.044;
d=0.97), although the latter two differences did not survive after control for multiple tests. In
the right-sided bottom-up amygdala-OMPFC EC during the happy experiment there was a
significant difference between BD and HC(U=26,p=0.003; d=1.32), and between depressed
de Almeida et al. Page 6
Biol Psychiatry. Author manuscript; available in PMC 2009 October 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
groups(U=45, p=0.026; d=0.41), although this latter difference did not survive after control
for multiple tests. During the sad experiment, there were differences between BD and HC
(U=40.5, p=0.025; d=0.53), MDD and HC(U=38.5,p=0.032; d=0.4), that did not survive after
controlling for multiple tests.
DISCUSSION
This is the first study to examine EC between key neural regions in emotion regulatory neural
systems in bipolar and major depression. We found that different patterns of abnormal left-
sided top-down OMPFC-amygdala during happy emotion labeling distinguished bipolar and
major depressed individuals(BD, MDD, respectively) from HC, while only BD differed from
HC on right-sided bottom-up amygdala-OMPFC EC. MDD showed significantly greater
negative left-sided top-down OMPFC-amygdala EC than HC, while BD showed significantly
reduced positive left-sided top-down OMPFC-amygdala EC and greater negative right-sided
bottom-up amygdala-OMPFC EC than HC.
The reduced left-sided top-down EC in the happy experiment in BD versus HC may reflect
reduced regulation of left amygdala by OMPFC –i.e. a “disconnection” –during positive
emotion processing. This parallels previous functional neuroimaging studies in BD reporting
abnormally increased left-sided amygdala and striatal activity to happy faces(19,21,38), and
abnormally decreased left-sided OMPFC activity during emotion regulation(41), that we
previously highlighted(42). This left-sided reduction in top-down OMPFC-amygdala EC,
possibly reflecting reduced regulation of amygdala by OMPFC during positive emotion
processing, may represent a predisposition to elevated mood and mania in BD. Conversely,
MDD showed left-sided top-down negative OMPFC-amygdala EC in the happy experiment.
This may reflect increased inhibition of the left amygdala by left OMPFC to positive emotional
stimuli that parallels previous functional neuroimaging findings in MDD of abnormally
reduced left striatal activity to positive emotional stimuli(36,43). The increased negative left-
sided top-down OMPFC-amygdala EC to happy faces may therefore represent an “over-
regulation” by OMPFC of the amygdala to these stimuli and a potential neural basis for the
increased negative and reduced positive emotional attentional bias that is frequently observed
in major depression(44). Together, these findings suggest that different patterns of abnormal
left-sided top-down OMPFC-amygdala EC during positive emotion processing may reflect
different neural mechanisms in bipolar and major depression, and also support a role of the left
hemisphere in positive emotion processing(32).
Only BD differed from HC on right-sided bottom-up amygdala-OMPFC EC during the happy
experiment: this was positive in HC and MDD but negative in BD, suggesting an inverse
functional relationship between right amygdala and OMPFC during happy emotion processing
in BD –i.e. less amygdala activity associated with greater OMPFC activity. This pattern of
abnormal right amygdala-OMPFC EC during the happy experiment is difficult to explain in
the context of the hemispheric specialization of emotion theory above, but does suggest
aberrant forward connectivity between right amygdala and right OMPFC during emotion
processing in bipolar more than major depression. This finding also suggests that bipolar
depression may be associated with functional abnormalities in neural systems supporting
emotion regulation in both hemispheres, while major depression may be associated with a
functional abnormalities predominantly within the left hemisphere, as has previously been
observed in human lesion studies(45–47), and is suggested by the loss of normal left-right
asymmetry in resting frontal activity in EEG studies of depression(48–51). The involvement
of functional abnormalities in both hemispheres in bipolar depression parallels our previous
observation of abnormalities in left and right amygdala-OMPFC white matter structure in
bipolar disorder(22).
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BD and MDD showed reduced left-sided top-down OMPFC-amygdala EC in the sad
experiment, but the overall between group differences did not survive correction for multiple
tests. This pattern of reduced left-sided EC in the sad experiment in both BD and MDD relative
to HC is also difficult to explain in the context of existing theories regarding hemispheric
specialization for emotion processing. Previous studies in MDD have, however, shown
increased FC after treatment with antidepressants between left-sided subcortical limbic and
OMPFC regions specifically during processing of negative emotional stimuli(52,53). This
suggests that abnormally reduced left-sided OMPFC and subcortical limbic functional
integration during negative emotion processing may be a state marker of depression in both
BD and MDD, and that this may ameliorate with treatment in MDD.
Another interpretation of these EC asymmetry findings is that this might reflect sampling error
and noise in making what is possibly a bilateral abnormality appears unilateral. While sampling
error may differ between slices(i.e. along the transversal axis), there is, however, no evidence
to suggest that it will also differ between homologous regions in the left and right hemispheres.
Moreover, our asymmetry findings are consistent with previous reports of asymmetry in MDD,
as we highlight above, as well as with our previous observation of asymmetric anatomical
connectivity asymmetry in BD.
An alternative interpretation of our overall findings is that abnormal OMPFC-amygdala EC in
BD and MDD might not be a specific correlate of labeling of emotional faces but a more general
correlate of face processing. The regions included in the DCM model, however, are well known
for their involvement in emotion processing and the task required participants to attend to the
emotional valence of the stimuli; therefore it is most likely that our findings reflect the
emotional component of the experiment.
There are limitations to this study. Almost all depressed individuals were medicated. This was
necessary, given the need to recruit individuals in severe depressed episode with either well-
established bipolar or recurrent major depression. We found no significant relationship
between medication load and left-sided top-down OMPFC-amygdala EC in the happy
experiment in BD, although there was a trend association between antipsychotics and this EC
measure in BD, suggesting that these medications may have increased EC rather than
contributing to our finding of abnormally decreased EC in BD. There was a significant positive
correlation between left-sided top-down OMPFC-amygdala EC in the happy experiment and
medication load in MDD, such that the greater the medication load, the less negative(i.e. less
abnormal) the EC. The latter finding also indicates an ameliorative rather than confounding
effect of medication upon this EC measure in MDD. When we further explored potential effects
of different subclasses of medication, we found a significant increase in this EC measures EC
only in MDD taking versus those not taking benzodiazepines. MDD also showed a negative
association between medication load and right-sided bottom-up amygdala-OMPFC EC, but
did not differ significantly form HC on this EC measure. Future studies could examine further
the potential effects of psychotropic medication upon EC in BD and MDD populations.
Another limitation of this study was age range of 18 and 55 years, it is possible that some MDD
may have not yet been beyond the age for possible development of bipolar disorder.
Interestingly, however, MDD showed a significant negative relationship between age of illness
onset and left-sided top-down OMPFC-amygdala EC during the happy experiment. MDD who
developed depression at an older age and later in adolescence or adulthood, and who were
therefore closer to being at the age beyond which it was less likely to develop bipolar disorder,
were, in fact, more likely to show negative top-down OMPFC-amygdala EC in the happy
experiment. This provides additional support for the pattern of negative left-sided top-down
OMPFC-amygdala EC in the happy experiment being MDD-specific. When we restricted our
analyses to females only, we observed a similar pattern of findings regarding abnormal EC in
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BD and MDD as demonstrated by the entire groups, indicating that differences in gender ratio
between groups did not contribute to our main findings.
Distinguishing bipolar disorder from major depression disorder depression is currently a major
challenge in clinical practice, with a correct diagnosis of BD in only 20% of BD within the
first year of seeking treatment(5), indicating a strong bias away from diagnosing bipolar
disorder in patients presenting in depressed episode. We show that bipolar depression and major
depression are associated with different patterns of abnormal functional integration between
different regions in neural systems supporting emotion regulation, in both hemispheres during
happy emotion processing. This finding in turn suggests that different pathophysiological
mechanisms may underlie these two types of depression, and is a promising step forward
toward identifying biological markers to distinguish between these different illnesses.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Schematic representation of the dynamic causal modeling
The face presentation entered (yellow arrow) the dynamic causal model through the amygdala
and propagated to OMPFC via bottom-up (red arrow), and back to the amygdala via top-down
(blue arrow) interconnections between the two regions through the unicinate fasciculus.
AMY: amygdala; OMPFC: orbitomedial pre-frontal cortex; A: anterior; P: posterior; L: left
and R: right side of the brain
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Figure 2. Effective Connectivity (EC) between OMPFC and amygdala
A. Representation of the bottom-up (red arrow) and top-down (blue arrow) endogenous
connection between left amygdala and left OMPFC
B. Left-sided top-down OMPFC-amygdala EC in the happy experiment Happy experiment:
negative EC in MDD relative to HC (**U=52, p=0.004; d=0.95) A close to zero effective
connectivity in BD when relative to HC (**U=52, p=0.007; d=0.65). There were no difference
between the two depressed groups on this EC measure (*U=83; p=0.14; d=0.67).
C. Right-sided bottom-up amygdala-OMPFC EC in the happy experiment Happy experiment:
reduced EC in MDD relative to HC (**U=110, p=0.5; d=0.37). A close to zero effective
connectivity in BD relative to HC (**U=42, p=0.002; d=1.2). There was a trend difference
between the two depressed groups on this EC measure (*U=64; p=0.027; d=0.42).
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